WuXi XDC Cayman (HKSE:02268) Price-to-Tangible-Book : 6.36 (As of May. 12, 2025)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Price-to-Tangible-Book?

As of today (2025-05-12), WuXi XDC Cayman's share price is HK$36.10. WuXi XDC Cayman's Tangible Book per Share of Dec. 2024 for the quarter that ended in Dec. 2024 was HK$5.68. Hence, WuXi XDC Cayman's Price to Tangible Book Ratio of today is 6.36.

The historical rank and industry rank for WuXi XDC Cayman's Price-to-Tangible-Book or its related term are showing as below:

HKSE:02268' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 5.46 Med: 6.11 Max: 6.76
Current: 6.36

During the past 5 years, WuXi XDC Cayman's highest Price to Tangible Book Ratio was 6.76. The lowest was 5.46. And the median was 6.11.

HKSE:02268's Price-to-Tangible-Book is ranked worse than
73.1% of 171 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.71 vs HKSE:02268: 6.36

A closely related ratio is called PB Ratio. As of today, WuXi XDC Cayman's share price is HK$36.10. WuXi XDC Cayman's Book Value per Sharefor the quarter that ended in Dec. 2024 was HK$5.91. Hence, WuXi XDC Cayman's P/B Ratio of today is 6.11.

WuXi XDC Cayman Price-to-Tangible-Book Historical Data

The historical data trend for WuXi XDC Cayman's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Price-to-Tangible-Book Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

6.76

5.46

WuXi XDC Cayman Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Tangible-Book	Get a 7-Day Free Trial			-	-	6.76	3.36	5.46

Competitive Comparison of WuXi XDC Cayman's Price-to-Tangible-Book

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's Price-to-Tangible-Book Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

WuXi XDC Cayman Price-to-Tangible-Book Calculation

WuXi XDC Cayman's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2024 )
	=	36.10	/	5.676
	=	6.36

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

WuXi XDC Cayman Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

L74:Germany

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

https://www.wuxixdc.com

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

Executives

Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si
Wu Xi Yao Ming Kang De Xin Yao Kai Fa Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Wuxi Biologics (cayman) Inc.	2101 Beneficial owner
Wuxi Apptec Co., Ltd.

WuXi XDC Cayman Headlines

No Headlines